25 XP   0   0   10

Hainan Huluwa Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Hainan Huluwa Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Hainan Huluwa Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hainan Huluwa Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hainan Huluwa Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Hainan Huluwa Pharmaceutical Group Co Ltd.

Quick analysis of Hainan Huluwa Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Hainan Huluwa Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
88.9%

What is your share worth?

Current worth
¥2.83
Expected worth in 1 year
¥3.15
How sure are you?
83.3%

+ What do you gain per year?

Total Gains per Share
¥0.38
Return On Investment
3.1%

For what price can you sell your share?

Current Price per Share
¥12.19
Expected price per share
¥9.51 - ¥14.35
How sure are you?
50%

1. Valuation of Hainan Huluwa Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥12.19

Intrinsic Value Per Share

¥-22.54 - ¥-26.90

Total Value Per Share

¥-19.71 - ¥-24.07

2. Growth of Hainan Huluwa Pharmaceutical Group Co Ltd (5 min.)




Is Hainan Huluwa Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$156.6m$134.2m$15m10.1%

How much money is Hainan Huluwa Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$3.1m$2.3m$852.3k27.0%
Net Profit Margin5.1%4.8%--

How much money comes from the company's main activities?

3. Financial Health of Hainan Huluwa Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Hainan Huluwa Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Hainan Huluwa Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Hainan Huluwa Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Hainan Huluwa Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Hainan Huluwa Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hainan Huluwa Pharmaceutical Group Co Ltd is ¥12.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hainan Huluwa Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hainan Huluwa Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.83. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hainan Huluwa Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.0%0.010.1%0.010.0%0.010.1%0.010.1%
Usd Book Value Change Per Share0.010.1%0.010.1%0.010.0%0.020.2%0.020.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.1%0.010.1%0.010.1%0.020.2%0.020.2%
Usd Price Per Share2.06-2.18-2.69-2.06-2.06-
Price to Earnings Ratio92.17-80.72--60.79-28.47-28.47-
Price-to-Total Gains Ratio208.76-224.86--687.64--44.46--44.46-
Price to Book Ratio5.26-5.86-8.07-6.20-6.20-
Price-to-Total Gains Ratio208.76-224.86--687.64--44.46--44.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.687096
Number of shares592
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.010.02
Gains per Quarter (592 shares)7.8214.24
Gains per Year (592 shares)31.2856.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15272155147
29535211103104
314808316154161
41910611422206218
52413314527257275
62815917633309332
73318620738360389
83821223844412446
94323926949463503
104726630055515560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%17.01.00.094.4%17.01.00.094.4%17.01.00.094.4%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%14.02.02.077.8%14.02.02.077.8%14.02.02.077.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%16.00.02.088.9%16.00.02.088.9%16.00.02.088.9%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%15.01.02.083.3%15.01.02.083.3%15.01.02.083.3%

Fundamentals of Hainan Huluwa Pharmaceutical Group Co Ltd

About Hainan Huluwa Pharmaceutical Group Co Ltd

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other therapeutic in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China.

Fundamental data was last updated by Penke on 2024-03-28 01:19:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hainan Huluwa Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hainan Huluwa Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.4% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 4.4%. The company is making a profit. +1
  • The TTM is 5.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM5.1%-0.7%
TTM5.1%YOY4.8%+0.4%
TTM5.1%5Y6.3%-1.2%
5Y6.3%10Y6.3%0.0%
1.1.2. Return on Assets

Shows how efficient Hainan Huluwa Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Assets means that Hainan Huluwa Pharmaceutical Group Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.9%-0.3%
TTM0.9%YOY0.9%0.0%
TTM0.9%5Y1.3%-0.4%
5Y1.3%10Y1.3%0.0%
1.1.3. Return on Equity

Shows how efficient Hainan Huluwa Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.5% Return on Equity means Hainan Huluwa Pharmaceutical Group Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM2.2%-0.7%
TTM2.2%YOY1.7%+0.5%
TTM2.2%5Y2.4%-0.2%
5Y2.4%10Y2.4%0.0%

1.2. Operating Efficiency of Hainan Huluwa Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hainan Huluwa Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Hainan Huluwa Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.5%-4.5%
TTM4.5%YOY8.0%-3.5%
TTM4.5%5Y6.6%-2.0%
5Y6.6%10Y6.6%0.0%
1.2.2. Operating Ratio

Measures how efficient Hainan Huluwa Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are ¥1.43 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 1.427. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.414. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.427TTM1.414+0.013
TTM1.414YOY1.310+0.104
TTM1.4145Y1.171+0.243
5Y1.17110Y1.1710.000

1.3. Liquidity of Hainan Huluwa Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hainan Huluwa Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.82 means the company has ¥1.82 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 1.818. The company is able to pay all its short-term debts. +1
  • The TTM is 1.456. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.818TTM1.456+0.362
TTM1.456YOY1.359+0.097
TTM1.4565Y1.548-0.093
5Y1.54810Y1.5480.000
1.3.2. Quick Ratio

Measures if Hainan Huluwa Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.70 means the company can pay off ¥0.70 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 0.697. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.562. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.697TTM0.562+0.135
TTM0.562YOY0.625-0.063
TTM0.5625Y0.641-0.080
5Y0.64110Y0.6410.000

1.4. Solvency of Hainan Huluwa Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hainan Huluwa Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.57 means that Hainan Huluwa Pharmaceutical Group Co Ltd assets are financed with 57.3% credit (debt) and the remaining percentage (100% - 57.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 0.573. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.562. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.573TTM0.562+0.011
TTM0.562YOY0.453+0.110
TTM0.5625Y0.446+0.116
5Y0.44610Y0.4460.000
1.4.2. Debt to Equity Ratio

Measures if Hainan Huluwa Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 139.3% means that company has ¥1.39 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The MRQ is 1.393. The company is able to pay all its debts with equity. +1
  • The TTM is 1.309. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.393TTM1.309+0.084
TTM1.309YOY0.829+0.479
TTM1.3095Y0.842+0.466
5Y0.84210Y0.8420.000

2. Market Valuation of Hainan Huluwa Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hainan Huluwa Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hainan Huluwa Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 92.17 means the investor is paying ¥92.17 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The EOD is 75.559. Based on the earnings, the company is expensive. -2
  • The MRQ is 92.171. Based on the earnings, the company is expensive. -2
  • The TTM is 80.722. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD75.559MRQ92.171-16.612
MRQ92.171TTM80.722+11.449
TTM80.722YOY-60.786+141.508
TTM80.7225Y28.473+52.250
5Y28.47310Y28.4730.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The EOD is -6.185. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.544. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.397. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.185MRQ-7.544+1.360
MRQ-7.544TTM-2.397-5.148
TTM-2.397YOY-35.660+33.264
TTM-2.3975Y-11.220+8.824
5Y-11.22010Y-11.2200.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hainan Huluwa Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hainan Huluwa Pharmaceutical Group Co Ltd:

  • The EOD is 4.310. Based on the equity, the company is fair priced.
  • The MRQ is 5.257. Based on the equity, the company is overpriced. -1
  • The TTM is 5.860. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.310MRQ5.257-0.948
MRQ5.257TTM5.860-0.602
TTM5.860YOY8.067-2.207
TTM5.8605Y6.199-0.340
5Y6.19910Y6.1990.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hainan Huluwa Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0490.081-39%0.040+22%0.157-69%0.157-69%
Book Value Per Share--2.8282.696+5%2.425+17%2.230+27%2.230+27%
Current Ratio--1.8181.456+25%1.359+34%1.548+17%1.548+17%
Debt To Asset Ratio--0.5730.562+2%0.453+27%0.446+29%0.446+29%
Debt To Equity Ratio--1.3931.309+6%0.829+68%0.842+65%0.842+65%
Dividend Per Share--0.0220.014+54%0.011+103%0.017+33%0.017+33%
Eps--0.0400.057-29%0.042-3%0.064-37%0.064-37%
Free Cash Flow Per Share---0.493-0.328-33%-0.117-76%-0.111-77%-0.111-77%
Free Cash Flow To Equity Per Share---0.493-0.072-85%-0.030-94%0.023-2261%0.023-2261%
Gross Profit Margin--1.0001.0000%1.0000%0.889+13%0.889+13%
Intrinsic Value_10Y_max---26.899--------
Intrinsic Value_10Y_min---22.538--------
Intrinsic Value_1Y_max---0.892--------
Intrinsic Value_1Y_min---0.875--------
Intrinsic Value_3Y_max---4.054--------
Intrinsic Value_3Y_min---3.843--------
Intrinsic Value_5Y_max---8.874--------
Intrinsic Value_5Y_min---8.118--------
Market Cap4877328612.480-22%5949620711.0406298715806.560-6%7776118259.520-23%5966291919.0400%5966291919.0400%
Net Profit Margin--0.0440.051-14%0.048-7%0.063-30%0.063-30%
Operating Margin---0.045-100%0.080-100%0.066-100%0.066-100%
Operating Ratio--1.4271.414+1%1.310+9%1.171+22%1.171+22%
Pb Ratio4.310-22%5.2575.860-10%8.067-35%6.199-15%6.199-15%
Pe Ratio75.559-22%92.17180.722+14%-60.786+166%28.473+224%28.473+224%
Price Per Share12.190-22%14.87015.743-6%19.435-23%14.9120%14.9120%
Price To Free Cash Flow Ratio-6.185+18%-7.544-2.397-68%-35.660+373%-11.220+49%-11.220+49%
Price To Total Gains Ratio171.134-22%208.758224.859-7%-687.637+429%-44.458+121%-44.458+121%
Quick Ratio--0.6970.562+24%0.625+12%0.641+9%0.641+9%
Return On Assets--0.0060.009-35%0.009-36%0.013-54%0.013-54%
Return On Equity--0.0150.022-31%0.017-13%0.024-37%0.024-37%
Total Gains Per Share--0.0710.095-25%0.051+39%0.174-59%0.174-59%
Usd Book Value--156622886.985149287083.834+5%134272624.105+17%123479919.339+27%123479919.339+27%
Usd Book Value Change Per Share--0.0070.011-39%0.006+22%0.022-69%0.022-69%
Usd Book Value Per Share--0.3910.373+5%0.336+17%0.309+27%0.309+27%
Usd Dividend Per Share--0.0030.002+54%0.002+103%0.002+33%0.002+33%
Usd Eps--0.0060.008-29%0.006-3%0.009-37%0.009-37%
Usd Free Cash Flow---27286071.762-18154541.056-33%-6452068.914-76%-5820209.606-79%-5820209.606-79%
Usd Free Cash Flow Per Share---0.068-0.045-33%-0.016-76%-0.015-77%-0.015-77%
Usd Free Cash Flow To Equity Per Share---0.068-0.010-85%-0.004-94%0.003-2261%0.003-2261%
Usd Market Cap675022279.967-22%823427506.408871742267.628-6%1076214767.118-23%825734801.5950%825734801.5950%
Usd Price Per Share1.687-22%2.0582.179-6%2.690-23%2.0640%2.0640%
Usd Profit--2233425.2163158923.279-29%2306538.318-3%2926285.006-24%2926285.006-24%
Usd Revenue--50376643.73560080035.613-16%51894927.598-3%43392434.499+16%43392434.499+16%
Usd Total Gains Per Share--0.0100.013-25%0.007+39%0.024-59%0.024-59%
 EOD+3 -5MRQTTM+10 -25YOY+14 -215Y+12 -2410Y+12 -24

3.2. Fundamental Score

Let's check the fundamental score of Hainan Huluwa Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1575.559
Price to Book Ratio (EOD)Between0-14.310
Net Profit Margin (MRQ)Greater than00.044
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.697
Current Ratio (MRQ)Greater than11.818
Debt to Asset Ratio (MRQ)Less than10.573
Debt to Equity Ratio (MRQ)Less than11.393
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.006
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Hainan Huluwa Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.568
Ma 20Greater thanMa 5012.640
Ma 50Greater thanMa 10012.670
Ma 100Greater thanMa 20014.439
OpenGreater thanClose12.200
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Income  1613,4463,607-2,8867219241,645-3,628-1,983



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,651,748
Total Liabilities1,520,080
Total Stockholder Equity1,091,422
 As reported
Total Liabilities 1,520,080
Total Stockholder Equity+ 1,091,422
Total Assets = 2,651,748

Assets

Total Assets2,651,748
Total Current Assets1,236,943
Long-term Assets1,414,804
Total Current Assets
Cash And Cash Equivalents 183,771
Net Receivables 474,234
Inventory 308,539
Other Current Assets 50,261
Total Current Assets  (as reported)1,236,943
Total Current Assets  (calculated)1,016,805
+/- 220,138
Long-term Assets
Property Plant Equipment 1,142,870
Goodwill 9,987
Intangible Assets 214,740
Long-term Assets Other 19,147
Long-term Assets  (as reported)1,414,804
Long-term Assets  (calculated)1,386,745
+/- 28,059

Liabilities & Shareholders' Equity

Total Current Liabilities680,479
Long-term Liabilities839,600
Total Stockholder Equity1,091,422
Total Current Liabilities
Short Long Term Debt 300,036
Accounts payable 167,909
Other Current Liabilities 8,930
Total Current Liabilities  (as reported)680,479
Total Current Liabilities  (calculated)476,875
+/- 203,604
Long-term Liabilities
Long term Debt 759,566
Long-term Liabilities  (as reported)839,600
Long-term Liabilities  (calculated)759,566
+/- 80,035
Total Stockholder Equity
Retained Earnings 342,980
Total Stockholder Equity (as reported)1,091,422
Total Stockholder Equity (calculated)342,980
+/- 748,442
Other
Capital Stock400,109
Common Stock Shares Outstanding 400,109
Net Debt 875,830
Net Invested Capital 2,151,024
Net Working Capital 556,464
Property Plant and Equipment Gross 1,142,870



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
1,120,376
0
0
1,116,380
1,182,492
1,388,306
1,521,160
1,525,005
1,402,409
1,478,429
1,760,930
1,700,839
1,797,426
1,831,160
2,312,057
2,352,978
2,545,246
2,651,748
2,651,7482,545,2462,352,9782,312,0571,831,1601,797,4261,700,8391,760,9301,478,4291,402,4091,525,0051,521,1601,388,3061,182,4921,116,380001,120,3760
   > Total Current Assets 
0
611,454
546,273
546,273
585,231
659,432
862,294
959,637
933,163
790,428
810,081
1,086,827
962,983
1,019,931
1,030,770
1,247,257
1,219,596
1,162,422
1,236,943
1,236,9431,162,4221,219,5961,247,2571,030,7701,019,931962,9831,086,827810,081790,428933,163959,637862,294659,432585,231546,273546,273611,4540
       Cash And Cash Equivalents 
0
151,569
0
0
54,013
94,840
214,177
345,877
276,515
269,472
227,910
487,681
207,191
174,387
187,083
480,369
334,185
222,970
183,771
183,771222,970334,185480,369187,083174,387207,191487,681227,910269,472276,515345,877214,17794,84054,01300151,5690
       Short-term Investments 
0
0
0
0
0
0
29,000
0
30,000
0
14,000
0
0
0
0
0
0
0
0
0000000014,000030,000029,000000000
       Net Receivables 
0
131,706
230,773
230,773
172,739
355,313
399,098
414,301
378,975
299,546
337,801
359,599
469,759
535,232
511,537
456,596
455,449
485,532
474,234
474,234485,532455,449456,596511,537535,232469,759359,599337,801299,546378,975414,301399,098355,313172,739230,773230,773131,7060
       Other Current Assets 
0
1,933
10,534
10,534
71,987
36,263
40,491
13,468
29,048
31,336
38,868
26,322
31,029
56,824
73,951
96,731
113,860
144,806
50,261
50,261144,806113,86096,73173,95156,82431,02926,32238,86831,33629,04813,46840,49136,26371,98710,53410,5341,9330
   > Long-term Assets 
0
508,922
0
0
531,150
523,060
526,011
561,523
591,841
611,981
668,348
674,103
737,855
777,494
800,390
1,064,800
1,133,382
1,382,824
1,414,804
1,414,8041,382,8241,133,3821,064,800800,390777,494737,855674,103668,348611,981591,841561,523526,011523,060531,15000508,9220
       Property Plant Equipment 
0
0
415,945
415,945
0
401,878
395,011
416,788
449,890
473,314
527,323
529,358
595,493
575,705
598,411
802,618
836,290
1,079,672
1,142,870
1,142,8701,079,672836,290802,618598,411575,705595,493529,358527,323473,314449,890416,788395,011401,8780415,945415,94500
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,987
9,987
9,9879,98700000000000000000
       Intangible Assets 
0
87,111
0
0
120,245
117,321
127,869
128,953
126,096
123,338
125,152
135,616
132,932
169,488
169,311
156,661
156,004
217,933
214,740
214,740217,933156,004156,661169,311169,488132,932135,616125,152123,338126,096128,953127,869117,321120,2450087,1110
       Other Assets 
0
0
41,714
41,714
0
3,862
3,131
19,861
20,064
19,765
24,256
30,754
31,063
34,326
36,702
139,730
178,283
120,165
0
0120,165178,283139,73036,70234,32631,06330,75424,25619,76520,06419,8613,1313,862041,71441,71400
> Total Liabilities 
0
475,123
0
0
455,450
496,043
518,256
604,682
579,943
490,418
540,987
830,406
740,422
809,628
829,186
1,296,792
1,297,290
1,433,212
1,520,080
1,520,0801,433,2121,297,2901,296,792829,186809,628740,422830,406540,987490,418579,943604,682518,256496,043455,45000475,1230
   > Total Current Liabilities 
0
413,178
398,849
398,849
417,666
460,866
497,400
544,524
456,420
356,163
449,705
793,946
705,047
753,230
765,265
1,056,888
868,961
817,919
680,479
680,479817,919868,9611,056,888765,265753,230705,047793,946449,705356,163456,420544,524497,400460,866417,666398,849398,849413,1780
       Short Long Term Debt 
0
60,000
0
0
171,326
216,316
274,337
210,278
209,208
162,319
256,326
438,982
361,171
451,902
517,102
500,951
418,286
363,329
300,036
300,036363,329418,286500,951517,102451,902361,171438,982256,326162,319209,208210,278274,337216,316171,3260060,0000
       Accounts payable 
0
185,238
121,993
121,993
153,067
95,892
121,517
126,034
133,529
76,906
80,440
149,127
194,605
125,848
152,001
47,016
246,091
210,148
167,909
167,909210,148246,09147,016152,001125,848194,605149,12780,44076,906133,529126,034121,51795,892153,067121,993121,993185,2380
       Other Current Liabilities 
0
62,818
72,781
72,781
36,933
63,069
61,700
138,127
85,780
52,577
55,902
127,461
89,203
88,024
74,847
363,230
183,593
155,382
8,930
8,930155,382183,593363,23074,84788,02489,203127,46155,90252,57785,780138,12761,70063,06936,93372,78172,78162,8180
   > Long-term Liabilities 
0
61,946
0
0
37,784
35,178
20,855
60,158
123,523
134,256
91,281
36,460
35,375
56,398
63,921
239,904
428,329
615,294
839,600
839,600615,294428,329239,90463,92156,39835,37536,46091,281134,256123,52360,15820,85535,17837,7840061,9460
       Other Liabilities 
0
0
27,321
27,321
0
8,885
8,855
8,112
12,871
12,424
11,977
32,359
31,860
53,544
61,998
61,499
61,001
80,603
0
080,60361,00161,49961,99853,54431,86032,35911,97712,42412,8718,1128,8558,885027,32127,32100
       Deferred Long Term Liability 
0
0
968
968
0
934
554
4,788
5,004
5,024
9,062
22,633
22,531
23,853
24,152
55,552
57,932
65,246
0
065,24657,93255,55224,15223,85322,53122,6339,0625,0245,0044,788554934096896800
> Total Stockholder Equity
0
645,253
0
0
660,931
686,449
870,050
916,478
940,178
908,376
933,822
928,206
958,120
985,831
1,000,092
1,013,888
1,054,448
1,075,283
1,091,422
1,091,4221,075,2831,054,4481,013,8881,000,092985,831958,120928,206933,822908,376940,178916,478870,050686,449660,93100645,2530
   Common Stock
0
0
360,009
360,009
0
360,009
400,109
400,109
400,109
400,109
400,109
400,109
400,109
400,109
400,109
400,109
400,109
400,109
0
0400,109400,109400,109400,109400,109400,109400,109400,109400,109400,109400,109400,109360,0090360,009360,00900
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
0
03000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,736,417
Cost of Revenue-863,675
Gross Profit872,743872,743
 
Operating Income (+$)
Gross Profit872,743
Operating Expense-1,583,896
Operating Income152,521-711,153
 
Operating Expense (+$)
Research Development67,834
Selling General Administrative608,337
Selling And Marketing Expenses-
Operating Expense1,583,896676,172
 
Net Interest Income (+$)
Interest Income2,548
Interest Expense-20,186
Other Finance Cost-1,371
Net Interest Income-19,009
 
Pretax Income (+$)
Operating Income152,521
Net Interest Income-19,009
Other Non-Operating Income Expenses-
Income Before Tax (EBT)120,326152,521
EBIT - interestExpense = -20,186
91,298
111,484
Interest Expense20,186
Earnings Before Interest and Taxes (EBIT)-140,512
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax120,326
Tax Provision-24,219
Net Income From Continuing Ops96,10796,107
Net Income91,298
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-19,009
 

Technical Analysis of Hainan Huluwa Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hainan Huluwa Pharmaceutical Group Co Ltd. The general trend of Hainan Huluwa Pharmaceutical Group Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hainan Huluwa Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hainan Huluwa Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 13.29 < 13.96 < 14.35.

The bearish price targets are: 12.10 > 9.51.

Tweet this
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hainan Huluwa Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hainan Huluwa Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current macd is -0.05055243.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hainan Huluwa Pharmaceutical Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hainan Huluwa Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hainan Huluwa Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current adx is 16.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hainan Huluwa Pharmaceutical Group Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hainan Huluwa Pharmaceutical Group Co Ltd. The current sar is 13.11.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current rsi is 42.57. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hainan Huluwa Pharmaceutical Group Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hainan Huluwa Pharmaceutical Group Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current cci is -108.13743219.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current cmo is -25.21966497.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hainan Huluwa Pharmaceutical Group Co Ltd. The current willr is -85.27131783.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Williams %R ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hainan Huluwa Pharmaceutical Group Co Ltd.

Hainan Huluwa Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current atr is 0.43877131.

Hainan Huluwa Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current obv is 236,230,448.

Hainan Huluwa Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hainan Huluwa Pharmaceutical Group Co Ltd. The current mfi is 66.63.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hainan Huluwa Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartHainan Huluwa Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hainan Huluwa Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Hainan Huluwa Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hainan Huluwa Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.568
Ma 20Greater thanMa 5012.640
Ma 50Greater thanMa 10012.670
Ma 100Greater thanMa 20014.439
OpenGreater thanClose12.200
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hainan Huluwa Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hainan Huluwa Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hainan Huluwa Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hainan Huluwa Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Hainan Huluwa Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hainan Huluwa Pharmaceutical Group Co Ltd.

Receive notifications about Hainan Huluwa Pharmaceutical Group Co Ltd in your mailbox!